1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ALLOGENE THERAPEUTICS INC
Allogene Therapeutics Inc XNAS: ALLO
2.08 0.03 (1.46%)
4.4M
XNAS Volume

XNAS 23 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Allogene Therapeutics Inc is on 03 Mar 2026 for the purpose of TD Cowen 46th Annual Health Care Conference See details

Allogene Therapeutics Inc - ALLO - stock price prediction, stock price target, analyst ratings from 15 analysts

Allogene Therapeutics Inc has a share price target of US$ 7 and profit growth estimate of 22.0% for Unknown Year, based on top 15 analyst calls.